Initially, SMARCB1 (SWI‐SNF‐related matrix‐associated actin‐dependent regulator of chromatin subfamily B member 1) was shown to be biallelically inactivated in malignant rhabdoid tumor cell lines (Versteege et al, 1998). This evidence concerns the gene SMARCB1 and rhabdoid tumor.